Two Tasmanian researchers tackling one of the most aggressive forms of brain cancer have been awarded scholarships by Cancer ...

A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for ...

A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for ...

An adjuvant personalized DNA vaccine caused no serious adverse events and extended overall survival in nine patients in a ...

Promising trial results: A personalized DNA vaccine for glioblastoma doubled two-year survival rates in a small phase 1 trial and showed no serious side effects. How it works: The vaccine targets up ...

Jason Collins, the NBA's first openly gay player who went on to become a pioneer for inclusion and an ambassador for the ...

Jason Collins, the NBA’s first openly gay player who went on to become a pioneer for inclusion and an ambassador for the ...

A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.

Participants in a clinical trial lived longer years longer after increased immune response to glioblastoma slowed progression ...